STOCKHOLM, Oct. 5
Scientists Karl Deisseroth, Peter Hegemann and Georg Nagel have won the 2026 Nobel Prize in Physiology or Medicine for discoveries that led to optogenetics, a breakthrough technique that allows researchers to control specific nerve cells with light and has transformed the study of the living brain.
The Nobel Committee recognised the three scientists for their discoveries concerning light-gated ion channels and optogenetics, work that has given researchers an unprecedented ability to investigate how individual neural circuits influence memory, emotions, behaviour and bodily functions.
Optogenetics combines genetic techniques with light to activate or inhibit selected groups of nerve cells with remarkable precision.
The technique addressed a fundamental problem that had confronted neuroscientists for decades.
Researchers could identify different regions of the brain and observe associations between brain activity and particular functions, but establishing direct cause and effect was considerably more difficult.
Optogenetics changed that by allowing scientists to switch particular nerve cells on or off and observe what happens.
The scientific journey behind the technique began far from the human brain.
Hegemann was studying Chlamydomonas, a single-celled alga capable of moving towards light.
In the early 2000s, Hegemann and Nagel discovered channelrhodopsin, a light-sensitive protein found in the alga’s cell membrane.
When exposed to blue light, channelrhodopsin opens a channel that allows electrically charged ions to flow into the cell. This generates an electrical signal.
The researchers subsequently established that the protein could be introduced into other types of cells, effectively giving those cells the ability to respond to light.
That discovery provided the biological mechanism that would eventually become central to optogenetics.
Deisseroth subsequently took the research into neuroscience.
He introduced the gene responsible for channelrhodopsin into nerve cells taken from rats and demonstrated that blue light could trigger electrical signals in those neurons.
The breakthrough was published in 2005.
Two years later, Deisseroth demonstrated that the same light-controlled mechanism could be used to manipulate nerve cells inside the brains of living mice.
The ability to selectively control neurons inside a living brain represented a major advance.
The approach became known as optogenetics and rapidly developed into one of the most important experimental tools in modern neuroscience.
Scientists can genetically target a particular population of neurons and make them responsive to light. By delivering carefully timed light pulses, they can then activate or suppress those neurons while observing the resulting changes.
That precision allows researchers to move beyond observing correlations between brain activity and behaviour.
They can test whether a particular neural circuit actually causes a specific response.
The technique has consequently provided researchers with new ways to investigate how the brain creates memories, regulates emotions and controls behaviour.
It has also become important in research into neurological and psychiatric disorders, where scientists are trying to understand how disruptions in specific neural circuits contribute to disease.
Per Svenningsson, chair of the Nobel Committee for Physiology or Medicine, said optogenetics had created possibilities for mapping the brain that scientists could once only imagine.
Its importance lies partly in the extraordinary complexity of the organ it helps researchers study.
The brain contains vast networks of interconnected neurons, with different circuits operating simultaneously.
Traditional techniques often lacked the precision needed to isolate one particular group of cells while leaving surrounding circuits largely unaffected.
Optogenetics gives researchers much finer control over that process.
The technology is also being investigated for possible medical applications.
One area of research involves attempts to restore vision in people with visual impairment by using light-sensitive proteins to make surviving retinal cells responsive to light.
Such applications remain an area of continuing scientific investigation, but they illustrate how a technology originally developed as a research tool could eventually contribute to new therapeutic approaches.
The discoveries honoured by the 2026 Nobel Prize also demonstrate how fundamental biological research can produce advances in seemingly unrelated fields.
Research into how a microscopic alga detects light ultimately provided scientists with a tool capable of manipulating individual neural circuits inside mammalian brains.
Hegemann and Nagel’s discovery of channelrhodopsin provided the molecular foundation. Deisseroth’s work demonstrated how that biological mechanism could be adapted to control neurons and investigate the brain.
Together, their discoveries gave neuroscience a way to move from observing the brain towards experimentally controlling specific components of its circuitry.
Optogenetics has since helped researchers build increasingly detailed maps linking individual neural circuits with memories, emotions, behaviour and physiological functions.
The 2026 Nobel Prize in Physiology or Medicine recognises that transformation.
What began with an attempt to understand how algae respond to light ultimately produced a technology that has changed how scientists investigate one of biology’s most difficult questions: how the activity of individual cells and circuits gives rise to the functions of the living brain.
